BeStock  
Stocks › Biotechnology › CLDX

Celldex Therapeutics CLDX

US equityMarket cap rank #2636Biotechnology
$27.42 −$0.54 (-1.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 -0.07%
Open$27.01
Prev close$27.96
Day range$26.64 – $28.43
Volume1.72M
Market cap$2.15B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$67.18+145.0% vs. price
  • Buy 91%
  • Hold 9%
Low $29.00Now $27.42Avg $67.18High $100.00

Recent rating changes

The last 20 actions on file set price targets from $29.00 to $100.00, averaging $65.25.

DateFirmRatingTarget
9 Nov 2026 CCORF BUY $68.00
9 Nov 2026 Morgan Stanley BUY $61.00
6 Nov 2026 Stifel BUY $68.00
6 Nov 2026 Goldman Sachs HOLD $29.00
6 Nov 2026 Guggenheim BUY $100.00
6 Nov 2026 H.C. Wainwright BUY $64.00
6 Nov 2026 Barclays BUY $53.00
5 Nov 2026 Cantor Fitzgerald BUY $72.00
20 Oct 2026 Morgan Stanley BUY $57.00
15 Oct 2026 Wells Fargo BUY $72.00
13 Oct 2026 Cantor Fitzgerald BUY $72.00
5 Oct 2026 H.C. Wainwright BUY $64.00
3 Oct 2026 LifeSci Capital BUY $64.00
2 Oct 2026 H.C. Wainwright BUY $64.00
28 Sep 2026 LifeSci Capital BUY $64.00
26 Sep 2026 LifeSci Capital BUY $56.00
23 Sep 2026 CCORF BUY $60.00
23 Sep 2026 Wells Fargo BUY $72.00
23 Sep 2026 Morgan Stanley BUY $57.00
23 Sep 2026 Leerink Partners BUY $88.00

Discussion

No comments yet — be the first to weigh in on CLDX.

Sign in to join the discussion.

Scroll to Top